February 15, 2008
RXi IPO Moving Forward
Worcester-based RXi Pharmaceuticals Corp. has taken another step toward going public, announcing today that the Securities and Exchange Commission has declared its registration statement effective.
RXi's parent company, Los Angeles-based CytRx Corp., said it plans to distribute shares in RXi to its current shareholders around March 11. After that, RXi will trade on the NASDAQ Capital Market under the symbol RXII.
Founded by Nobel Prize winner Craig Mello, RXi pursues disease treatments based on RNA interference.
RXi's parent company, Los Angeles-based CytRx Corp., said it plans to distribute shares in RXi to its current shareholders around March 11. After that, RXi will trade on the NASDAQ Capital Market under the symbol RXII.
Founded by Nobel Prize winner Craig Mello, RXi pursues disease treatments based on RNA interference.
WBJ Web Partners
Most Recent
Most Recent
0 Comments